Nuvectis Pharma, Inc. (NVCT)
21.08
+0.06
(+0.29%)
USD |
NASDAQ |
Nov 10, 16:00
21.19
+0.11
(+0.52%)
After-Hours: 20:00
Nuvectis Pharma Market Cap : 541.27M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 541.27M |
| November 09, 2026 | 539.73M |
| November 06, 2026 | 536.90M |
| November 05, 2026 | 456.02M |
| November 04, 2026 | 474.25M |
| November 03, 2026 | 496.59M |
| November 02, 2026 | 492.48M |
| October 30, 2026 | 493.32M |
| October 29, 2026 | 495.72M |
| October 28, 2026 | 490.12M |
| October 27, 2026 | 492.25M |
| October 26, 2026 | 493.59M |
| October 23, 2026 | 535.23M |
| October 22, 2026 | 557.65M |
| October 21, 2026 | 552.58M |
| October 20, 2026 | 549.65M |
| October 19, 2026 | 505.60M |
| October 16, 2026 | 496.52M |
| October 15, 2026 | 505.33M |
| October 14, 2026 | 480.51M |
| October 13, 2026 | 484.51M |
| October 12, 2026 | 525.62M |
| October 09, 2026 | 563.79M |
| October 08, 2026 | 537.37M |
| October 07, 2026 | 541.64M |
| Date | Value |
|---|---|
| October 06, 2026 | 534.70M |
| October 05, 2026 | 571.00M |
| October 02, 2026 | 585.15M |
| October 01, 2026 | 553.12M |
| September 30, 2026 | 563.79M |
| September 29, 2026 | 548.04M |
| September 28, 2026 | 555.52M |
| September 25, 2026 | 539.77M |
| September 24, 2026 | 577.41M |
| September 23, 2026 | 562.46M |
| September 22, 2026 | 613.98M |
| September 21, 2026 | 586.75M |
| September 18, 2026 | 587.29M |
| September 17, 2026 | 570.73M |
| September 16, 2026 | 583.82M |
| September 15, 2026 | 585.15M |
| September 14, 2026 | 623.32M |
| September 11, 2026 | 640.41M |
| September 10, 2026 | 600.37M |
| September 09, 2026 | 608.11M |
| September 08, 2026 | 640.41M |
| September 04, 2026 | 653.76M |
| September 03, 2026 | 650.55M |
| September 02, 2026 | 638.54M |
| September 01, 2026 | 615.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Opus Genetics, Inc. | 349.60M |
| Faeth Therapeutics, Inc. | 333.88M |
| ACADIA Pharmaceuticals, Inc. | 3.159B |
| Alnylam Pharmaceuticals, Inc. | 20.30B |
| Anika Therapeutics, Inc. | 180.42M |
Market Cap Related Metrics
| PEG Ratio | -0.275 |
| Price to Book Value | 4.274 |
| Price | 21.08 |
| Earnings Yield | -8.84% |
| PEGY Ratio | -0.275 |